Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-20 Purchase | 2024-08-22 5:51 pm | Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT | 48,387 | $0.65 | $31,452 | 122,461 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-02 6:02 pm | N/A 2034-01-31 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT | 145,000 | $0 | 145,000 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:43 pm | N/A 2033-08-31 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 545,000 | $0 | 545,000 (Direct) | View |
Ownership | 2023-09-06 5:40 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 0 | $0 | 74,074 (Direct) | View |
| 2020-12-01 Disposition | 2020-12-03 9:41 pm | N/A N/A | Neurotrope Inc. | NTRP | Ryan Charles S. Director 10% Owner | 557,695 | $0 | 0 (Direct) | View |
| 2020-11-24 Option Award | 2020-11-27 5:09 pm | N/A 2030-11-24 | Neurotrope Inc. | NTRP | Ryan Charles S. Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-16 5:00 pm | N/A 2029-12-13 | Neurotrope Inc. | NTRP | Ryan Charles S. Chief Executive Officer | 130,680 | $0 | 130,680 (Direct) | View |